Search for: "Price v. International Paper" Results 601 - 620 of 639
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Jul 2008, 7:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC affirms validity and enforceability of Eisai’s compound patent on Aciphex; elucidates current standard for obviousness of chemical composition of matter patents: Eisai v Reddy’s Lab’s and Teva Pharma: (Orange Book Blog), (Patent Docs), (Patent Prospector), (IP Law360), (Hal Wegner), (Patent Baristas),… [read post]
11 Jul 2008, 4:30 am
Part I – Spicy IP), India: Discussion of grant of Indian patents to Cipla for Fosamax derivative and Nexium derivative: (Spicy IP), India: Draft National Biotechnology Regulatory Authority Bill: (Spicy IP), Ivory Coast: Ivorians increasingly choose fake medicines on price: (Afro-IP), Mexico: New Mexican medicaments approvals regime: an early report: (IP tango), UK: Leave to appeal refused in trade mark infringement proceedings between Eli Lilly and 8PM Chemist concerning the… [read post]
20 Jun 2008, 8:07 am
: (IP ThinkTank), Standing committee on the law of patents to reconvene after two year hiatus: (Intellectual Property Watch), IP Menu News – PDF download of patent documents: (IP Menu News), Changes to PCT filing fees: (Patent Docs), The OOXML standard: a paper tiger? [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation amendments to dodge real… [read post]
4 Jun 2008, 3:28 am
Here is a great position paper/study by a Forensic Psychologist, named Steven J. [read post]
23 May 2008, 1:00 pm
  This recalls to mind the scolding that Justice William Brennan gave to counsel for Price Waterhouse in the Supreme Court case of Price Waterhouse v. [read post]
23 May 2008, 1:03 am
- Generic manufacturers aggressively promote expensive doxofylline over price controlled equivalent theophylline: (Spicy IP), Middle East – Ranbaxy strengthens presence in Middle East region: (GenericsWeb), Scotland: Future funding of stem cell companies in Scotland dependent on EPO Enlarged Board of Appeals’ decision on stem cell patentability: (IP finance), South Africa: More on AIDS/access debate - Patrick Bond article on Thabo Mbeki’s AIDS policy: (Afro-I [read post]
16 May 2008, 8:03 am
– Discussion of  T Berg’s paper ‘IP and the preferential option for the poor’: (ISinIP), Patent valuation: differing analytical methods: (Hal Wegner) Global - Copyright Copyright as an engine of free expression? [read post]
2 May 2008, 7:00 am
, India: Mint story on patent loophole in India regarding the importation of generics: (Spicy IP), India: WHO lambasts Indian drug regulatory system: (Spicy IP), India: Minister to ensure that reduced excise duty to reflect in drug prices: (Spicy IP), India: SCC journal article ‘Intellectual property rights and the challenges faced by the pharmaceutical industry’: (Spicy IP), Poland: Trade marks for medicines: (Class 46), US: IPO publishes letter… [read post]
19 Apr 2008, 8:50 am
Once price becomes a material part of a client's selection criteria, unfortunately, firms have put one foot on an escalator that goes in only one direction. [read post]
8 Apr 2008, 8:05 am
Mailed submissions may be paper, disk, or CD-ROM. [read post]
4 Apr 2008, 1:00 am
- Counterfeit cash flooding the market: (Afro-IP), Debranded fakes for Liberia: an update: (Afro-IP), South African music industry blames pirates for falling sales of local artists: (Afro-IP), Plaintiff obtains interlocutory relief in patent case Sanitam Services Limited v Bins (Nairobi) Services Limited: (Afro-IP), South Africa – new patent judgments: Buckman Laboratories v Bromine Compounds; Northpark Trading 3 (Pty) Ltd v Ausplow (Pty) Ltd:… [read post]
28 Mar 2008, 6:00 am
’: (LawFont.com)BrazilElectronic copies of oppositions now available on internet: (International Law Office)CanadaSam Trosow on latest CMEC copyright bulletins: (Michael Geist),ComputerWorld Canada on copyright reform: (Michael Geist),Deemed abandonment provisions pose traps for the unwary: (International Law Office),Trade mark appeals: stays and service requirements: (Canadian Trademark Blog),Franchising into Canada: (IP finance),More Champagne, anyone? [read post]
24 Mar 2008, 4:30 am
  Marciano overcame pretrial dismissal by weaving together a complex factual scenario suggesting that all three owners collaborated for various financial accounting and tax reasons in creating on paper an ownership structure that masked or at least departed from the parties' internal agreement. [read post]
29 Feb 2008, 8:00 am
: (Securing Innovation),Mike Masnick on IP: (Patent Troll Tracker),Trifurcation and IP valuation: (IP finance),Jordan Hatcher article ‘Implementing open data: the open data commons project’: (opencontentlawyer.com),Online markets and IP trading exchanges: (IP finance),INTERPOL announces an international IP crime database: (Class 46), (Spicy IP),New free IP database: WIPO magazine launched! [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is… [read post]